Business

Research & Development Division

Awards

As a result of researchers’ efforts since its founding, KAKEN researchers have been awarded the following prestigious prizes in the past.

  • 2012
    Best Presentation Award for the 27th annual meeting of Academy of Pharmaceutical Science and Technology, Japan (APSTJ) “In Vitro-In Vivo Correlation of Percutaneous Drug Absorption:Prediction of Percutaneous Absorption Based on an In Vitro Skin Permeability Assay”
  • 2011
    Prize for the Outstanding Pharmaceutical Science Thesis from the Academy of Pharmaceutical Science and Technology, Japan (APSTJ)
    “Formulation Design of Latanoprost Eye Drops to Improve the Stability at Room Temperature”
  • 2009
    Asahi Kasei Pharmaceutical Science Encouraging Award from the Academy of Pharmaceutical Science and Technology, Japan(APSTJ)
    “Formulation Design of Itraconazole Tablets Containing the Novel Solid Dispersion Controlled the Mean Particle Size to 120 µm or less”
  • 2003
    The 7th Journal of Pharmaceutical Science and Technology, Japan Prize for the Most Outstanding Thesis from the Academy of Pharmaceutical Science and Technology, Japan(APSTJ)
    “Research on Rapidly-disintegrating Tablets Using the Surface-modifying Method”
  • 2001
    ASBMR (American Society for Bone & Mineral Research ) Young Investigator Award, 23rd Annual Meeting in Phoenix, USA “Novel, Non-steroidal Selective Androgen Receptor Modulators ( SARMs ) Increase Bone Mass and Reduce Androgenic Virilizing Effects in Adult Osteoporotic Rats”
  • 1999
    The 14th Annual Orthopedic Research Meeting of the Japanese Orthopedic Association “Acceleration of Fracture Healing in Monkeys by Basic Fibroblast Growth Factor complexed with Biodegradable Hydrogel”
  • 1998
    Japan Pharmaceutical Society Prize
    “Development of a stable PGI2 analog, Sodium Beraprost”
  • 1995
    The 41th Okochi Memorial Prize
    “Development and Industrialization of Sodium Beraprost”
  • 1994
    The 40th Okochi Memorial Prize
    “Development of a topical antifungal agent, Butenafine Hydrochloride”